129 related articles for article (PubMed ID: 2343159)
41. Feasibility of management of high-grade cervical lesions in a single visit: a randomized controlled trial.
Brewster WR; Hubbell FA; Largent J; Ziogas A; Lin F; Howe S; Ganiats TG; Anton-Culver H; Manetta A
JAMA; 2005 Nov; 294(17):2182-7. PubMed ID: 16264159
[TBL] [Abstract][Full Text] [Related]
42. Audit of cervical cancer screening and colposcopy attendance in rural South Africa.
Knegt Y
Afr J Reprod Health; 2014 Dec; 18(4):70-8. PubMed ID: 25854095
[TBL] [Abstract][Full Text] [Related]
43. Attitudes to Papanicolaou smears.
Conway K
J Psychosom Obstet Gynaecol; 1996 Dec; 17(4):189-94. PubMed ID: 8997684
[TBL] [Abstract][Full Text] [Related]
44. Intraepithelial neoplasia of the uterine cervix in the teenager.
Feldman MJ; Kent DR; Pennington RL
Cancer; 1978 Apr; 41(4):1405-8. PubMed ID: 639001
[TBL] [Abstract][Full Text] [Related]
45. Abnormal Papanicolaou smears and colposcopic follow-up among American Indian and Alaska Native women in the Pacific northwest.
Gilbert TJ; Sugarman JR; Cobb N
J Am Board Fam Pract; 1995; 8(3):183-8. PubMed ID: 7618496
[TBL] [Abstract][Full Text] [Related]
46. Human papilloma virus testing knowledge and attitudes among women attending colposcopy clinic with ASCUS/LGSIL pap smears.
Le T; Hicks W; Menard C; Boyd D; Hewson T; Hopkins L; Kee Fung MF
J Obstet Gynaecol Can; 2004 Sep; 26(9):788-92. PubMed ID: 15361273
[TBL] [Abstract][Full Text] [Related]
47. Predicting nonattendance for colposcopy clinic follow-up after referral for an abnormal Pap smear.
Kavanagh AM; Simpson JM
Aust N Z J Public Health; 1996 Jun; 20(3):266-71. PubMed ID: 8768416
[TBL] [Abstract][Full Text] [Related]
48. Exploring the Cervical Cancer Screening Experiences of Black Lesbian, Bisexual, and Queer Women: The Role of Patient-Provider Communication.
Agénor M; Bailey Z; Krieger N; Austin SB; Gottlieb BR
Women Health; 2015; 55(6):717-36. PubMed ID: 25909663
[TBL] [Abstract][Full Text] [Related]
49. Cervical Screening and Colposcopy Management of Women Age 24 and Under.
Buick C; Jembere N; Wang L; Kupets R
J Obstet Gynaecol Can; 2020 Dec; 42(12):1518-1524. PubMed ID: 32988802
[TBL] [Abstract][Full Text] [Related]
50. Sociodemographic factors associated with cervical cancer screening and follow-up of abnormal results.
Elit L; Krzyzanowska M; Saskin R; Barbera L; Razzaq A; Lofters A; Yeritsyan N; Bierman A
Can Fam Physician; 2012 Jan; 58(1):e22-31. PubMed ID: 22267636
[TBL] [Abstract][Full Text] [Related]
51. Cervical cancer screening: who is not screened and why?
Harlan LC; Bernstein AB; Kessler LG
Am J Public Health; 1991 Jul; 81(7):885-90. PubMed ID: 2053665
[TBL] [Abstract][Full Text] [Related]
52. Women's experiences in coping with abnormal Papanicolaou results and follow-up colposcopy.
Lauver DR; Baggot A; Kruse K
J Obstet Gynecol Neonatal Nurs; 1999; 28(3):283-90. PubMed ID: 10363540
[TBL] [Abstract][Full Text] [Related]
53. Video colposcopy improves adherence to follow-up compared to regular colposcopy: a randomized trial.
Takacs P; Chakhtoura N; De Santis T
Arch Gynecol Obstet; 2004 Nov; 270(3):182-4. PubMed ID: 15205983
[TBL] [Abstract][Full Text] [Related]
54. The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women.
Goldie SJ; Weinstein MC; Kuntz KM; Freedberg KA
Ann Intern Med; 1999 Jan; 130(2):97-107. PubMed ID: 10068381
[TBL] [Abstract][Full Text] [Related]
55. Comparative utility of repeat Papanicolaou smears, cervicography, and colposcopy in the evaluation of atypical Papanicolaou smears.
Spitzer M; Krumholz BA; Chernys AE; Seltzer V; Lightman AR
Obstet Gynecol; 1987 May; 69(5):731-5. PubMed ID: 3106869
[TBL] [Abstract][Full Text] [Related]
56. The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors.
Cox JT;
Arch Pathol Lab Med; 2003 Aug; 127(8):950-8. PubMed ID: 12952506
[TBL] [Abstract][Full Text] [Related]
57. The effect of educational brochures on knowledge and emotional distress in women with abnormal Papanicolaou smears.
Stewart DE; Lickrish GM; Sierra S; Parkin H
Obstet Gynecol; 1993 Feb; 81(2):280-2. PubMed ID: 8423964
[TBL] [Abstract][Full Text] [Related]
58. Inner-city African American women who failed to receive cancer screening following a culturally-appropriate intervention: the role of health insurance.
Sung JF; Alema-Mensah E; Blumenthal DS
Cancer Detect Prev; 2002; 26(1):28-32. PubMed ID: 12088200
[TBL] [Abstract][Full Text] [Related]
59. Race-specific results of Papanicolaou testing and the rate of cervical neoplasia in the National Breast and Cervical Cancer Early Detection Program, 1991-1998 (United States).
Benard VB; Lee NC; Piper M; Richardson L
Cancer Causes Control; 2001 Jan; 12(1):61-8. PubMed ID: 11227926
[TBL] [Abstract][Full Text] [Related]
60. Predictors of adherence to follow-up recommendations after an abnormal Pap smear among underserved inner-city women.
Miller SM; Tagai EK; Wen KY; Lee M; Hui SA; Kurtz D; Scarpato J; Hernandez E
Patient Educ Couns; 2017 Jul; 100(7):1353-1359. PubMed ID: 28190541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
